Author

Yasunori Ueda

Director, Cardiovascular Division, Osaka National Hospital - Cited by 13,806 - Cardiology

Biography

Dr. Yasunori Ueda is an Associate professor in the department of Hematology and Oncology, Cardiovascular Division, Osaka National Hospital, located in Japan. His study interests major Haematological malignancy, Non-tumour disease, Hematopoietic cell transplantation. In recent years, he has studied several Chronic myeloid leukemia(CML),Myeloproliferative disorder (other than CML). Currently , Dr.Yasunori Ueda is the author/editors/reviewer in several international journals. He published 10 articles in many journals and the articles are informative and got goodcitations.
Title
Cited by
Year
JCS 2022 guideline focused update on diagnosis and treatment in patients with stable coronary artery disease
S Nakano, S Kohsaka, T Chikamori, K Fukushima, Y Kobayashi, ...Circulation Journal 86 (5), 882-915, 2022202
24
2022
Extrapolating long-term event-free and overall survival with dapagliflozin in patients with heart failure and reduced ejection fraction: an exploratory analysis of a phase 3 …
KF Docherty, PS Jhund, B Claggett, JP Ferreira, O Bengtsson, ...JAMA cardiology 6 (11), 1298-1305, 2021202
17
2021
The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis
T Abe, H Matsuo, R Abe, S Abe, H Asada, A Ashida, A Baba, K Eguchi, ...Therapeutic Apheresis and Dialysis 25 (6), 728-876, 2021202
16
2021
An open-label, single-arm, multicenter study of ibrutinib in Japanese patients with steroid-dependent/refractory chronic graft-versus-host disease
N Doki, M Toyosaki, S Shiratori, T Osumi, M Okada, T Kawakita, M Sawa, ...Transplantation and Cellular Therapy 27 (10), 867. e1-867. e9, 2021202
14
2021
Dasatinib-based 2-step induction for adults with Philadelphia chromosome–positive acute lymphoblastic leukemia
I Sugiura, N Doki, T Hata, R Cho, T Ito, Y Suehiro, M Tanaka, S Kako, ...Blood Advances 6 (2), 624-636, 2022202
12
2022
Consensus document on the standard of coronary angioscopy examination and assessment from the Japanese Association of Cardiovascular Intervention and Therapeutics
Y Mitsutake, H Yano, T Ishihara, H Matsuoka, Y Ueda, T UenoCardiovascular Intervention and Therapeutics, 1-5, 2022202
9
2022
Aortic plaque burden predicts vascular events in patients with cardiovascular disease: the EAST-NOGA study
K Kojima, S Komatsu, T Kakuta, D Fukamachi, S Kimura, H Fujii, ...Journal of Cardiology 79 (1), 144-152, 2022202
8
2022
Long‐term outcomes and clinical predictors of mortality following occurrence of stent thrombosis
T Ishihara, K Okada, H Kida, T Tsujimura, O Iida, S Okuno, Y Hata, ...Journal of the American Heart Association 11 (7), e023276, 2022202
8
2022
Manual thrombus aspiration and its procedural stroke risk in myocardial infarction
Y Sotomi, Y Ueda, S Hikoso, D Nakatani, S Suna, T Dohi, H Mizuno, ...Journal of the American Heart Association 10 (22), e022258, 2021202
7
2021
Prognostic impact of echocardiographic congestion grade in HFpEF with and without atrial fibrillation
H Abe, S Kosugi, T Ozaki, T Mishima, M Date, Y Ueda, M Uematsu, ...JACC: Asia 2 (1), 3-84, 2022202
7
2022
Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning
M Iwasaki, J Kanda, Y Arai, T Kondo, T Ishikawa, Y Ueda, K Imada, ...Blood advances (8), 218-227, 2022202
6
2022
Complete bone marrow necrosis with Charcot-Leyden crystals caused by myeloid neoplasm with mutated NPM1 and TET2
K Saito, T Sato, K Notohara, Y Nannya, S Ogawa, Y UedaInternal Medicine 61 (21), 3265-3269, 2022202
4
2022
Outcome of therapy‐related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched …
H Itonaga, M Kida, A Hamamura, N Uchida, Y Ozawa, T Fukuda, Y Ueda, ...Hematological Oncology 0 (), 752-762, 2022202
4
2022
Fulminant myocarditis after the first dose of mRNA-1273 vaccination in a patient with previous COVID-19: a case report
K Horiuchi, S Kosugi, H Abe, Y UedaEuropean Heart Journal-Case Reports 6 (7), ytac290, 2022202
4
2022
Relation of left atrial overload indices with prognostic endpoints in heart failure and preserved ejection fraction
S Hoshida, K Tachibana, Y Shinoda, T Minamisaka, M Seo, M Yano, ...ESC Heart Failure 9 (3), 178-1791, 2022202
4
2022
Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation for myelodysplastic syndrome: a retrospective study from the Adult …
T Konuma, Y Shimomura, K Ishiyama, T Ara, H Nakamae, N Hiramoto, ...American journal of hematology 97 (12), E7-E50, 2022202
4
2022
Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with …
A Sunaga, S Hikoso, S Tamaki, M Seo, M Yano, T Hayashi, A Nakagawa, ...ESC Heart Failure 9 (), 1801-1811, 2022202
3
2022
Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion
Y Tamai, H Ohto, H Yasuda, A Takeshita, N Fujii, H Ogo, Y Yazawa, ...Transfusion 61 (9), 2718-2726, 2021202
3
2021
Single Cord Blood Transplantation Versus HLA-Haploidentical Related Donor Transplantation Using Post-Transplant Cyclophosphamide in Patients with Hematological Malignancies
F Wada, J Kanda, S Yoshioka, T Ishikawa, T Akasaka, Y Ueda, H Hirata, ...Blood 138, 97, 010
2
2021
Phase 1/2 study evaluating the safety and efficacy of DSP‐7888 dosing emulsion in myelodysplastic syndromes
Phase 1/ study evaluating the safety and efficacy of DSP‐7888 dosing emulsion in myelodysplastic syndromesY Ueda, K Usuki, J Fujita, I Matsumura, N Aotsuka, N Sekiguchi, ...Cancer Science 113 (4), 1377-139, 0
2
2022

Referred From: https://scholar.google.com/citations?user=bN77xBAAAAAJ&hl=en

Cited by
Citations 13806
h-index 57
i10-index 233
Recommended Journals
Open Access Journals